GENFLEET THERAPEUTICS
GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.
GENFLEET THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.genfleet.com
Total Employee:
11+
Status:
Active
Contact:
021-6882 1388
Total Funding:
169.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS DigiCert SSL Encryption Everywhere
Current Employees Featured
Wang Yu Chief Medical Officer @ GenFleet Therapeutics
Chief Medical Officer
Qiang LU Chairman and Founder @ GenFleet Therapeutics
Chairman and Founder
2017-09-01
Lan Jiong Founder and CEO @ GenFleet Therapeutics
Founder and CEO
Founder
Investors List
Dyee Capital
Dyee Capital investment in Series C - GenFleet Therapeutics
CDH Investments
CDH Investments investment in Series C - GenFleet Therapeutics
ABC International
ABC International investment in Series C - GenFleet Therapeutics
Wenzhou Dongchuang Xinhui
Wenzhou Dongchuang Xinhui investment in Series C - GenFleet Therapeutics
Qiaojing Eastern Investment
Qiaojing Eastern Investment investment in Series C - GenFleet Therapeutics
Shanjin Capital
Shanjin Capital investment in Series C - GenFleet Therapeutics
Suxin Venture Capital
Suxin Venture Capital investment in Series C - GenFleet Therapeutics
Baidu Ventures
Baidu Ventures investment in Series C - GenFleet Therapeutics
CHERAMI
CHERAMI investment in Series C - GenFleet Therapeutics
Huagai Capital
Huagai Capital investment in Series C - GenFleet Therapeutics
Official Site Inspections
http://www.genfleet.com Semrush global rank: 7.74 M Semrush visits lastest month: 437
- Host name: 120.26.129.103
- IP address: 120.26.129.103
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "GenFleet Therapeutics"
GenFleet Overview-GenFleet Therapeutics
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies, is dedicated to serving significant global unmet medical needs in oncology and …See details»
劲方医药_首页
Genfleet therapeutics 劲方医药是一家全球布局的临床阶段创新药物开发企业。 公司聚焦肿瘤、免疫类疾病领域高度未满足的临床需求，以疾病生物学机理和临床转化医学为核心，构建并发挥 …See details»
GenFleet Therapeutics - Crunchbase Company Profile & Funding
GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level …See details»
Genfleet Therapeutics (Shanghai), Inc. - Drug pipelines, Patents ...
Some of the most advanced RIPK1 contenders include phase 1-stage programs by China’s GenFleet Therapeutics, Roche’s U.S. company Genentech, and a compound developed by Eli …See details»
GenFleet Therapeutics - LinkedIn
GenFleet's rich and diversified pipeline highlights multiple cutting-edge products with novel mechanisms and global intellectual property rights. Through years of endeavor, GenFleet has …See details»
GenFleet Therapeutics - VentureRadar
GenFleet has a robust and novel pipeline spanning across numerous oncology and immunology therapeutic indications. Our target class includes: signal transduction regulators, tumor …See details»
BioCentury - GenFleet: building a fleet of first-in-class cancer and ...
Dec 7, 2023 GenFleet was founded in 2017 to pursue oncology and immunology targets backed by strong scientific rationale but lacking clinical validation, bucking the trend of Chinese …See details»
Genfleet Company Profile 2024: Valuation, Funding & Investors
Genfleet General Information Description. Developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing …See details»
GenFleet Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
GenFleet Therapeutics - Contacts, Employees, Board Members
GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.See details»
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for ...
Apr 19, 2024 GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug …See details»
GenFleet Therapeutics - Craft
GenFleet Therapeutics is a company that develops and researches molecular pharmaceuticals targeting cancer treatments. The company specializes in developing molecular-level …See details»
SELLAS Life Sciences Signs Exclusive License Agreement with …
Mar 31, 2022 - SELLAS In-licenses Worldwide Rights Outside of Greater China for Clinical-Stage Asset - - Completion of Ongoing Phase 1 Trial in the United States/China Expected by …See details»
GenFleet Therapeutics
GenFleet Therapeutics is a clinical-stage biotechnology company focusing on first-in-class therapies in oncology and immunology.See details»
China's GenFleet banks $58M for cancer, autoimmune pipeline: …
Mar 10, 2020 GenFleet Therapeutics raised $58 million in series B funding to bankroll clinical trials of its pipeline, including a small molecule for liver cancer.See details»
Resilience, Innovation, Empowerment-GenFleet Therapeutics
GenFleet Therapeutics is a clinical-stage biotechnology company focusing on first-in-class therapies in oncology and immunology.See details»
GenFleet Therapeutics and Merck Enter into Trial Collaboration to ...
Dec 19, 2022 GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies, is dedicated to serving significant global unmet medical needs in …See details»
GenFleet Therapeutics - Products, Competitors, Financials, …
GenFleet Therapeutics is a clinical-stage innovative drug development company operating in the healthcare and pharmaceutical industry. The company focuses on the development of novel …See details»
BioLineRx Announces Collaboration Agreement with GenFleet …
Jun 28, 2022 GenFleet Therapeutics is a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, founded in 2017 by veteran drug …See details»